Research conducted at the Lady Davis Institute provides proof of concept that an existing drug holds promise for reversing loss of memory and brain lesions associated with Alzheimer disease.
New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology (AD) in an animal model. Importantly, this drug has already proven to be non-toxic for humans in a clinical setting and could, therefore, be brought quickly to trials in humans against AD. These findings are published today in Nature Communications.
For years, Dr. Andréa LeBlanc, Senior Investigator at the LDI and Professor of Neurology and Neurosurgery at McGill University, has strived to identify early neurodegenerative events responsible for age-related memory loss. Her team discovered that the Caspase-6 enzyme is highly activated in Alzheimer disease brain lesions and associated with loss of memory. She, therefore, pursued the hypothesis that stopping Caspase-6 might provide relief from memory loss and stop progressive dementia. Since there are no specific Caspase-6 inhibitors, the LeBlanc team moved upstream, ultimately discovering that Caspase-1 was responsible for activating Caspase-6.
“This was a significant revelation because Caspase-1 inhibitors had been developed for treating inflammatory diseases,” explains Dr. LeBlanc. “Thus, we decided to test the effects of a particular Caspase-1 inhibitor, called VX-765, against memory loss and brain pathologies in a mouse model of Alzheimer disease.”
The work, first authored by Dr. Joseph Flores, a research associate in the LeBlanc lab, showed that VX-765 has an unprecedented beneficial effect in Alzheimer mice. The drug rapidly reverses memory loss, eliminates inflammation, and stops Alzheimer’s prototypical amyloid peptide accumulation in the mice brains. In addition to being safe for humans at relatively high doses for extended periods of time, it is capable of reaching the brain, a significant challenge in the development of drugs against disorders of the brain.
While Dr. LeBlanc cautions that there is a considerable bridge to cross between the mouse brain and that of a human, she believes that since her work has first identified the Caspase-1/Caspase-6 neurodegenerative pathway in human neurons and in human Alzheimer brains, there is a chance that this drug will work just as well in humans as it did in mice. Nevertheless, a clinical trial is needed to determine whether the drug will be beneficial against Alzheimer disease in humans.
Presently, there are no efficient treatments to significantly treat Alzheimer disease, the major affliction in a group of dementias that affect 47.5 million individuals worldwide.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Your old iPods can spark music memories for Fifers with alzheimers on December 14, 2018 at 2:53 am
The power of music to unlock memories in those experiencing the advance of Alzheimers is the basis for an innovative approach to patient care being introduced across the NHS in Fife. Already bringing ... […]
- Senate passes Alzheimers legislation on December 13, 2018 at 11:18 am
After unanimous passage the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act in the U.S. Senate, the legislation now goes to the House of Representatives for consideration. The ... […]
- Little Falls police complete new Alzheimer's awareness training on December 9, 2018 at 4:19 am
Police interaction with individuals who suffer from Alzheimer's disease is not limited to when they become confused and lost. A person's chances of interaction with police increase with a dementia dia... […]
- Q-Tip Reveals That he’s a Caregiver for his Mother Who Suffers From Alzheimers and Dementia on December 5, 2018 at 8:32 am
Q-Tip is pretty low-key about his personal life but he recently gave us a little insight on his day-to-day life on Instagram. Tip has his own Beats 1 Radio called Abstract Radio and announced that ... […]
- Deputies find missing man with Alzheimers on August 9, 2018 at 5:10 am
MEMPHIS, TN (WMC) - Shelby County Sheriff's Office found a man with Alzheimers who went missing. Tyrone Cotton, 61, had been last seen around noon Tuesday on foot. Deputies found him walking aimlessly ... […]
- Easy exhaustion in shift work may indicate later risk of Alzheimers: Finnish study on July 6, 2018 at 3:24 pm
HELSINKI, July 6 (Xinhua) -- A research directed by professor Tiina Paunio of the Finnish National Institute for Health and Welfare (THL) has found a genetic connection between being easily exhausted ... […]
- James City Lions receive briefing on Alzheimers on April 26, 2018 at 1:10 pm
Mr. Douglas Panto (Alzheimer's Association Community Program Manager) recently addressed JC Lions Club members about the differences between dementia and Alzheimers. One of his primary missions is to ... […]
- The Cheater's Guide to Beating Alzheimers: New Research and Prevention Breakthroughs on April 6, 2018 at 3:09 am
Sometimes I walk into a room and can’t remember why. I lose my keys. I blank on names. So I wonder: Could I be heading for Alzheimer’s, the way my dad and my grandmother did? Or is there a way I can b... […]
- 'We're not going to give up on him:' Hockey coach, 56, facing Alzheimers with grit, love on March 4, 2018 at 5:23 am
The Malettes lace up — hockey skates, naturally — and glide effortlessly, arm in arm, at twilight. There’s no sign of just how rough the ice has been for the Orléan’s family since Vince Malette, a for... […]
via Bing News